Carisma Therapeutics Inc. 3 SEC Filings

Filed On	Filing
02 Jan 2025	Form 3: McAndrew Natalie, Vice President of Finance No securities owned
01 Nov 2024	Form 3: Cheng Sohanya Roshan, Director No securities owned
01 Jul 2024	Form 3: Thorell Marella, Director No securities owned
01 Jul 2024	Form 3: Scadden David, Director No securities owned
01 Apr 2024	Form 3: Hohneker John, Director No securities owned
13 Mar 2023	Form 3: ModernaTX, Inc., 10% owner Holds 5,059,338 shares of Common Stock
09 Mar 2023	Form 3: Kelly Steven, Director No securities owned
09 Mar 2023	Form 3: Ugwumba Chidozie, Director No securities owned
09 Mar 2023	Form 3: Hodits Regina, Director No securities owned
09 Mar 2023	Form 3: Klichinsky Michael, Chief Scientific Officer No securities owned
09 Mar 2023	Form 3: Morris Richard Steven, Chief Financial Officer No securities owned
09 Mar 2023	Form 3: Torok Michael, Director No securities owned
09 Mar 2023	Form 3: Zweifach Sanford S, Director No securities owned
09 Mar 2023	Form 3: Odlander Bjorn, Director No securities owned
09 Mar 2023	Form 3: Morrison Briggs, Director No securities owned
26 Jan 2022	Form 3: Rosales Minori, Chief Development Officer No securities owned
21 Jul 2021	Form 3: Jewett Michael A. S., Director No securities owned
21 Jul 2021	Form 3: Honig Peter, Director No securities owned
03 Jun 2021	Form 3: Drake Patricia M., Chief Commercial Officer No securities owned
10 May 2021	Form 3: Ryu Elly, Principal Accounting Officer Holds 11,696 shares of Common Stock

Comments